Relationship between ustekinumab trough concentrations and both clinical and biological remission in patients with Crohn's disease

被引：1
|
作者：
Dominguez, Francisco Angel Lao [1 ]
Lozano, Maria Jose Fobelo [1 ]
Pizarraya, Antonio Gutierrez [1 ]
Fernandez, Manuel Castro [2 ]
机构：
[1] Univ Hosp Virgen Valme, Pharm Serv, Seville, Spain
[2] Hosp Univ Virgen Valme, Digest Med Serv, Seville, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2023年 / 46卷 / 08期
关键词：
D O I：
10.1016/j.gastrohep.2022.10.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：631 / 632
页数：2
相关论文
共 50 条
  • [31] ASSOCIATION BETWEEN SERUM USTEKINUMAB CONCENTRATIONS AND ENDOSCOPIC DISEASE ACTIVITY IN CROHN'S DISEASE
    Di Fonzo, David M.
    Alabdulkarim, Balqis
    Yanofsky, Russell
    Abduallah, Yaqeen
    Golovics, Petra A.
    Lakatos, Peter L.
    Bitton, Alain
    Wild, Gary
    Afif, Waqqas
    Bessissow, Talat
    GASTROENTEROLOGY, 2023, 164 (06) : S882 - S883
  • [32] Ustekinumab and remission in perianal Crohn's disease: A case report
    Alcantara-Figueroaa, C. E.
    Coronado-Rivera, E. F.
    Estela-Vasquezb, E. F.
    Calderon-Cabreraa, D. C.
    Alcantara-Ascon, R. A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (04): : 431 - 432
  • [33] SHORTER DISEASE DURATION IN PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH HIGHER RATES OF REMISSION WITH USTEKINUMAB
    Gold, Stephanie
    Agrawal, Manasi
    Jairath, Vipul
    Galati, Jonathan S.
    Coburn, Elliot
    Click, Benjamin H.
    Peerani, Farhad
    Narula, Neeraj
    Zullow, Samantha
    Ahmed, Waseem
    Barsky, Maria
    Johnson, Amanda M.
    Dang, Thucnhi T.
    Garg, Rajat
    Aggarwal, Manik
    Mohammad, Danah
    Halloran, Brendan P.
    Kochhar, Gursimran
    Todorowski, Hannah
    Mohy-Ud-Din, Nabeeha
    Izanec, James L.
    Teeple, Amanda M.
    Gasink, Christopher
    Muser, Erik
    Ding, Zhijie
    Swaminath, Arun
    Lakhani, Komal
    Hogan, Daniel
    Datta, Samit
    Singh, Siddharth
    Boland, Brigid
    Bohm, Matthew
    Fischer, Monika
    Sashi, Sagi
    Bruining, David H.
    Kane, Sunanda V.
    Loftus, Edward V.
    Afzali, Anita
    Ullman, Thomas
    Lawlor, Garrett
    Baumgart, Daniel C.
    Chang, Shannon
    Hudesman, David
    Lukin, Dana J.
    Sandborn, William J.
    Scherl, Ellen J.
    Siegel, Corey A.
    Regueiro, Miguel D.
    Colombel, Jean Frederic
    Sands, Bruce E.
    GASTROENTEROLOGY, 2021, 160 (06) : S701 - S702
  • [34] Microinflammation in patients with Crohn's disease in clinical remission
    Maharshak, Nitsan
    Zilberman, Liaz
    Arbel, Yaron
    Shapira, Itzhak
    Berliner, Shlomo
    Arber, Nadir
    Dotan, Iris
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (04): : 310 - 314
  • [35] RISANKIZUMAB MAINTAINS REMISSION IN PATIENTS WITH CROHN'S DISEASE ELECTIVELY SWITCHED FROM USTEKINUMAB
    Smyth, Matthew
    Spencer, Elizabeth A.
    Ungaro, Ryan C.
    Said, Hyder
    Zinger, Adar
    Choi, David
    Rubin, David T.
    Dubinsky, Marla C.
    GASTROENTEROLOGY, 2024, 166 (05) : S1143 - S1143
  • [36] Clinical utility of ustekinumab in Crohn's disease
    Kotze, Paulo Gustavo
    Ma, Christopher
    Almutairdi, Abdulelah
    Panaccione, Remo
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 35 - 47
  • [37] Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease
    Painchart, Claire
    Brabant, Severine
    Duveau, Nicolas
    Nachury, Maria
    Desreumaux, Pierre
    Branche, Julien
    Gerard, Romain
    Prevost, Clementine Lauriot Dit
    Wils, Pauline
    Lambin, Thomas
    Boualit, Medina
    Labalette, Myriam
    Pariente, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (05) : 1445 - 1452
  • [38] Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease
    Claire Painchart
    Séverine Brabant
    Nicolas Duveau
    Maria Nachury
    Pierre Desreumaux
    Julien Branche
    Romain Gérard
    Clémentine Lauriot Dit Prevost
    Pauline Wils
    Thomas Lambin
    Médina Boualit
    Myriam Labalette
    Benjamin Pariente
    Digestive Diseases and Sciences, 2020, 65 : 1445 - 1452
  • [39] Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients
    Di Fonzo, David M. P.
    Alabdulkarim, Balqis
    Yanofsky, Russell
    Abduallah, Yaqeen
    Golovics, Petra
    Lakatos, Peter L.
    Bitton, Alain
    Wild, Gary
    Afif, Waqqas
    Bessissow, Talat
    CROHNS & COLITIS 360, 2024, 6 (04)
  • [40] Modelling of the relationship between ustekinumab exposure, faecal calprotectin and endoscopic outcomes in patients with Crohn's disease
    Wang, Z.
    Verstockt, B.
    Vermeire, S.
    Sabino, J.
    Ferrante, M.
    Declerck, P.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S335 - S336
12345